Analyst provides a high price target for Viking Therapeutics stock.
2 reports, 1 independent
Updated Oct 12
Gone quiet
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Analyst provides a high price target for Viking Therapeutics stock.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Keep exploring
The entities involved
-
Viking Therapeutics
company in San Diego, United States
-
Cantor Fitzgerald
American financial services company
Related events
- Leerink Partners, Truist Financial, HSBC, and Cantor Fitzgerald raised target prices on various stocks on October 9, 2026.
- Cantor Fitzgerald increased its price target on Eli Lilly and Company stock.
- Cantor Fitzgerald raised its price target and gave an overweight rating for SOL Strategies Inc. on October 11, 2026.
- Cantor Fitzgerald raised price targets and reaffirmed ratings, while TD Cowen adjusted its ratings for Paylocity on August 7, 2026.
- Analyst firms issued price targets and ratings involving Benchmark, Booking Holdings, and Cantor Fitzgerald.